WellSpan Health has named Laureen T. Driscoll as its next president and chief executive officer, appointing a career nurse who rose to run one of the largest hospital groupings on the United States west coast.
Driscoll joins from Providence, where she serves as chief executive of the South Division, a territory spanning Northern and Southern California. In that role she has had oversight of seventeen hospitals, a workforce of roughly 41,000 and net operating revenue of about 10.3 billion dollars. She joined Providence in 2022 after senior operating roles at MultiCare Health System.
She succeeds Roxanna Gapstur, who has led the Pennsylvania system since January 2019 and who signalled her intention to retire earlier this year. Gapstur remains in post through the start of January, with Driscoll taking up the role the following day, an orderly handover that gives the incoming chief executive a defined transition rather than an abrupt one.
The appointment followed a national search run by the board search committee with the executive search firm Korn Ferry. Joe Crosswhite, chair of the WellSpan Health board of directors, described the incoming chief executive as a proven and mission driven leader, and the board weighed candidates drawn from health systems across the country before settling on an operator from outside Pennsylvania.
The choice is a conventional one for a system of this size, and conventional in a way that is worth reading. The group runs twelve hospitals across south central Pennsylvania and northern Maryland, a footprint that is regional rather than national, and the board has gone to a candidate whose recent experience is of running a far larger and more complex division inside a national system. That is a hire for scale and for operating discipline rather than for local continuity.
It also continues a pattern visible across the American provider sector, in which systems of this size increasingly recruit divisional chief executives out of the large multi state groups rather than promoting from within. The logic is straightforward enough. A divisional chief executive at a national system has already carried a profit and loss account larger than the whole of the hiring organisation, and has done so under the margin pressure that now defines the sector.
The clinical background is the other half of the story. Nurse trained chief executives remain a minority at the top of large American health systems, and both the outgoing and the incoming chief executive hold nursing qualifications, which is unusual enough to read as a deliberate signal about how the board sees the job.
The handover is scheduled for the opening days of 2027. The outgoing chief executive will have completed eight years in the role, a tenure comfortably above the sector average, and she leaves a system that has expanded its ambulatory and community footprint over that period. Her successor inherits an organisation that is not in distress, which is a materially different task from the turnaround mandates that have dominated recent chief executive appointments in American healthcare.
